Updated recommendation by the nomination committee of Navamedic ASA

Navamedic announces the final outcome in the offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

Navamedic publishes a supplement to the offer document regarding the unconditional cash offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

Navamedic publishes a supplement to the offer document regarding the unconditional cash offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

Navamedic ASA: Notice of Annual General Meeting